Evidence for increased functional vascular Na+/K+ pump activity in the obese Zucker rat

Hypertension Research - Clinical and Experimental

Volumn 21, Issue 4, 1998, Pages 283-288

  Golub, Michael S ^b   Chang, Chwen Tzuei ^a   Tuck, Michael L ^c   Berger, Morris E ^c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^c NONE

Author keywords

Adenosine triphosphatase; Blood vessels; Diabetes; Hyperinsulinism; Hypertension; Potassium; Sodium

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); INSULIN; POTASSIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMORAL ARTERY; HYPERINSULINISM; HYPERTENSION; MALE; NERVE STIMULATION; NONHUMAN; OBESITY; RAT; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; TAIL ARTERY; VASCULAR SMOOTH MUSCLE;

EID: 0032432809     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.21.283     Document Type: Article

References (48)

1. Reaven GM, Hoffman BB: A role for insulin in the aetiology and course of hypertension? Lancet 1987; 2: 435-436.
2. Hwang I, Ho H, Hoffman BB, Reaven GM: Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987; 10: 512-516.
3. Brands MW, Hildebrandt DA, Mizelle HL, Hall JE: Sustained hyperinsulinemia increases arterial pressure in conscious rats. Am J Physiol 1991; 260: R764-R768.
4. Zucker LM: Pancreatic insulin release and peripheral tissue resistance in Zucker obese rats fed high and low-carbohydrate diets. Am J Physiol 1975; 228: 543-548.
5. Kasiske BL, O'Donnell MP, Keane WF: The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. Hypertension 1992; 19: I-110-I-115.
6. 45Ca efflux and hypertension in Zucker obese rats. J Vasc Med Biol 1989; 1: 278-282.
7. Kurtz TW, Morris RC, Pershadsingh HA: The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension 1989; 13: 896-901.
8. Bray GA, York DA: Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol Rev 1979; 59: 719-809.
9. +) ATPase: two mechanisms of stimulation. J Biol Chem 1991; 266: 15824-15831.
10. +)-ATPase transport activity in muscle. J Biol Chem 1985; 260: 6206-6212.
11. 1-adrenergic events in rat and rabbit aorta. Pharmacology 1986; 33: 224-234.
12. Kahn AM, Seidel CL, Allen JC, O'Neil RG, Shelat H, Song T: Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle. Hypertension 1993; 22: 735-742.
13. Webb RC, Bohr DF: Potassium relaxation of vascular smooth muscle from spontaneously hypertensive rats. Blood Vessels 1979; 16: 71-79.
14. Pamnani MB, Clough DL, Haddy FJ: Altered activity of the sodium-potassium pump in arteries of rats with steroid hypertension. Clin Sci Mol Med 1978; 4 (Suppl): 41s-43s.
15. + pump activity in the vasculature of fructose-fed hyperinsulinemic and hypertensive rats. Hypertens Res 1998; 21: 73-80.
16. Landsberg L: Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system and adaptive thermogenesis. Q J Med 1986; 61: 1081-1090.
17. Zemel MB, Reddy SR, Sowers JR: Insulin attenuation of vasoconstrictor responses to phenylephrine in Zucker lean and obese rats. Am J Hypertens 1991; 4: 537-539.
18. Cox RH, Kikta DC: Age-related changes in thoracic aorta of obese Zucker rats. Am J Physiol 1992; 262: H1548-H1556.
19. Zemel MB, Reddy SR, Shehin SE, Lockette W, Sowers JR: Vascular reactivity in Zucker rats: role of insulin resistance. J Vasc Med Biol 1990; 2: 81-85.
20. Levin BE, Triscari J, Sullivan AC: Abnormal sympatho-adrenal function and plasma catecholamines in obese Zucker rats. Pharmacol Biochem Behav 1980; 13: 107-113.
21. Berger ME, Golub MS, Chang C, et al: Flavonoid potentiation of contractile responses in rat blood vessels. J Pharmacol Exp Ther 1992; 263: 78-83.
22. Gershon MD: Effects of tetrodotoxin on innervated smooth muscle preparations. Br J Pharmacol 1966; 29: 259-279.
23. + ATPase activity in vascular smooth muscle. Blood Vessels 1978; 15: 198-207.
24. Sampson SR, Brodie C, Alboim SV: Role of protein kinase C in insulin activation of the Na-K pump in cultured skeletal muscle. Am J Physiol 1994; 266: C751-C758.
25. + pump activity by insulin and nitric oxide in rabbit aorta. Am J Physiol 1996; 270: H1287-H1293.
26. +/ATPase gene expression by insulin in vascular smooth muscle cells. Am J Hypertens 1993; 6: 626-629.
27. Sowers JR: Effects of insulin and IGF-1 on vascular smooth muscle glucose and cation metabolism. Diabetes 1996; 45: 47-51.
28. +-ATPase regulation in Dahl salt-sensitive and salt-resistant rats. J Biol Chem 1988; 263: 11056-11058.
29. Haddy FJ: Digitalis-like circulating factor in hypertension: potential messenger between salt balance and intracellular sodium. Cardiovasc Drugs Ther 1990; 4: 343-349.
30. + uptake in rat adipocytes. J Biol Chem 1980; 255: 10938-10945.
31. Soltis EE, Field FP: Sodium pump activity and calcium relaxation in vascular smooth muscle of deoxycorticosterone acetate-salt rats. Hypertension 1986; 8: 1032-1039.
32. Shimosawa T, Ando K, Ono A, et al: Insulin inhibits norepinephrine overflow from peripheral sympathetic nerve ending. Biochem Biophys Res Comm 1992; 188: 330-335.
33. Shimosawa T, Ando K, Fujita T: Effect of insulin on norepinephrine overflow at peripheral sympathetic nerve endings in young spontaneously hypertensive rats. Am J Hypertens 1996; 9: 1119-1125.
34. Dengler H, Spiegel HE, Titus ED: Uptake of tritium-labeled norepinephrine in brain and other tissue of cat in vitro. Science 1961; 133: 1072-1073.
35. Kopin IJ: Catecholamine metabolism: basic aspects and clinical significance. Hypertension 1985; 28: 1047-1054.
36. Yamazaki T, Akiyama T, Kitagawa H, Takauchi Y, Kawada T: Elevation of either axoplasmic norepinephrine or sodium level induced release of norepinephrine from cardiac sympathetic nerve terminals. Brain Res 1996; 737: 343-346.
37. Bunnag P, Hori MT, Ormsby B, Berger ME, Golub MS, Tuck ML: Impaired in vivo adrenergic responses in diet-induced hypertensive rats. Hypertens Res 1996; 20: 17-21.
38. Tuck ML: Obesity, the sympathetic nervous system and essential hypertension. Hypertension 1992; 19: 167-177.
39. Zemel MB, Peuler JD, Sowers JR, Simpson L: Hypertension in insulin-resistant Zucker obese rats is independent of sympathetic neural support. Am J Physiol 1992; 262: E368-E371.
40. Hall JE, Brands MW, Kivlighn SD, Mizelle HL, Hildebrandt DA, Gaillard CA: Chronic hyperinsulinemia and blood pressure: interaction with catecholamines? Hypertension 1990; 15: 519-527.
41. Yagi S, Takata S, Kiyokawa H, et al: Effects of insulin on vasoconstrictive responses to norepinephrine and angiotensin II in rabbit femoral artery and vein. Diabetes 1988; 37: 1064-1067.
42. Saito F, Hori MT, Fittingoff M, Tuck ML: Insulin attenuates agonist mediated calcium mobilization in cultured rat vascular smooth muscle cells. J Clin Invest 1993; 92: 1161-1167.
43. Standley PR, Ram JL, Sowers JR: Insulin attenuation of vasopressin-induced calcium responses in arterial smooth muscle from zucker rats. Endocrinology 1993; 133: 1693-1699.
44. Wambach GK, Liu D: Insulin attenuates vasoconstriction by noradrenaline, serotonin and potassium chloride in rat mesenteric arterioles. Clin Exp Hypertens A 1992; A14: 733-740.
45. Kasiske BL, Cleary MP, O'Donnell MP, Keane WF: Effects of genetic obesity on renal structure and function in the Zucker rat. J Lab Clin Med 1985; 106: 598-604.
46. Reddy SR, Kotchen TA: Dietary sodium chloride increases blood pressure in obese Zucker rats. Hypertension 1992; 20: 389-393.
47. Pawloski CM, Kanagy NL, Mortensen LH, Fink GD: Obese Zucker rats are normotensive on normal and increased sodium intake. Hypertension 1992; 19: 190-195.
48. Kim JH, Snider T, Abel M, Zemel MB: Hypertension in young, healthy Zucker obese rats is not responsive to reduced salt intake. J Nutr 1994; 124: 713-716.